View in EDS

GM3(Neu5Gc) ganglioside: an evolution fixed neoantigen for cancer immunotherapy.

Saved in:

Bibliographic Details
Title:	GM3(Neu5Gc) ganglioside: an evolution fixed neoantigen for cancer immunotherapy.
Authors:	Labrada M; Immunobiology Division, Molecular Immunology Institute, Center of Molecular Immunology (CIM), Playa, Havana, Cuba., Dorvignit D; Immunobiology Division, Molecular Immunology Institute, Center of Molecular Immunology (CIM), Playa, Havana, Cuba., Hevia G; Immunobiology Division, Molecular Immunology Institute, Center of Molecular Immunology (CIM), Playa, Havana, Cuba., Rodríguez-Zhurbenko N; Tumor Biology Division, Molecular Immunology Institute, CIM, Playa, Havana, Cuba., Hernández AM; Tumor Biology Division, Molecular Immunology Institute, CIM, Playa, Havana, Cuba., Vázquez AM; Tumor Biology Division, Molecular Immunology Institute, CIM, Playa, Havana, Cuba., Fernández LE; Innovation Division, Molecular Immunology Institute, CIM, Playa, Havana, Cuba. Electronic address: luis@cim.sld.cu.
Source:	Seminars in oncology [Semin Oncol] 2018 Jan; Vol. 45 (1-2), pp. 41-51. Date of Electronic Publication: 2018 May 07.
Publication Type:	Journal Article; Review
Journal Info:	Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0420432 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-8708 (Electronic) Linking ISSN: 00937754 NLM ISO Abbreviation: Semin Oncol Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1532-8708
DOI:	10.1053/j.seminoncol.2018.04.003